Scottsdale, AZ 4/9/2007 10:06:53 PM
News / Business

Quality Stocks Client News - Cord Blood America CEO Matthew Schissler Says White House Endorsement of Stem Cell Legislation Could End Controversies

In Quality Stocks Client News Today Cord Blood America, Inc. (CBAI.OB), the umbilical cord blood stem cell preservation company focused on bringing the life saving potential of stem cells to families nationwide and internationally, said today it salutes the news that the White House will back legislation that provides federal funding for stem-cell research using certain embryonic cells.

  

"It is important to move this research forward, so that scientists can tell us more about the feasibility of using stem cells to combat some of the most dangerous and difficult diseases, including cancer and heart disease," said Matthew L. Schissler, CEO, Cord Blood America. Umbilical cord blood stem cells are already used to treat more than 70 major diseases, including leukemia, metabolic blood disorders and immune deficiencies.

 

"While the umbilical cord blood stem cells we collect and preserve are not controversial, it is important that the entire stem cell sector be free to move forward with research and not legislative brawling," Mr. Schissler said. "We are encouraged that Congress, the White House and other participants can find compromises so medical research can advance, bringing the United States closer to the competitive global leaders in stem cell research." Cord Blood America is now the 4th largest umbilical cord blood stem cell company in the world.

 

About Cord Blood America, Inc. (CBAI)

Cord Blood America is the parent company of CorCell, which facilitates umbilical cord blood stem cell preservation for expectant parents and their children. Its mission is to be the most respected stem cell preservation company in the industry. Collected through a safe and non-invasive process, cord blood stem cells offer a powerful and potentially life-saving resource for treating a growing number of ailments, including cancer, leukemia, blood, and immune disorders. To find out more about Cord Blood America, Inc. visit our website at www.corcell.com

 

For investor information, visit www.cordblood-america.com

About QualityStocks

Small Cap Stock Newsletter QualityStocks is a free service that collects data from hundreds of Small-Cap and Micro-Cap online Investment Newsletters into one free Daily Newsletter Report.

 

To sign up for “The QualityStocks Daily Newsletter” please visit www.QualityStocks.net

 

The Quality Stocks Daily Newsletter http://Newsletter.QualityStocks.net

 

The Quality Stocks Daily Video in High Definition http://Video.QualityStocks.net

 

The Quality Stocks Daily Blogs http://Blog.QualityStocks.net

 

Michael McCarthy
Director of Business Development

QualityStocks

http://www.QualityStocks.net

480.308.0703

mailto:editor@QualityStocks.net